Gene · 6491
Papers1,377
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,377
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemia. | Sci Transl Med | 2025 | 40238916 | PubTator, text mining | PubMed |
| Lysosome-associated CASM: from upstream triggers to downstream effector mechanisms. | Front Cell Dev Biol | 2025 | 40213394 | PubTator, text mining | PubMed |
| Prediction of neoadjuvant chemotherapy efficacy and prognostic biomarker analysis in patients with triple-negative breast cancer. | Front Pharmacol | 2025 | 40144666 | PubTator, text mining | PubMed |
| Clinical, Immunologic, and Genetic Characteristics of T-lymphoblastic Leukemia with STIL-TAL1 Fusion. | Clin Lab | 2025 | 40066532 | PubTator, text mining | PubMed |
| Whole-exome sequencing identifies EP300 variants associated with visceral leishmaniasis relapse. | Int J Biol Macromol | 2025 | 40020829 | PubTator, text mining | PubMed |
| SIL-TAL1-Positive Adult T-ALL with t(11;14)(p15;q11.2): A Rare Case Report Highlighting Prognostic Challenges and Treatment Implications. | J Inflamm Res | 2025 | 39991668 | PubTator, text mining | PubMed |
| Interactions of N- and C-terminal parts of Ana1 permitting centriole duplication but not elongation. | Open Biol | 2025 | 39904373 | PubTator, text mining | PubMed |
| The MCPH7 Gene Product STIL Is Essential for Dendritic Spine Formation. | Cells | 2025 | 39851490 | PubTator, text mining | PubMed |
| Interaction of STIL with FOXM1 regulates SF3A3 transcription in the hepatocellular carcinoma development. | Cell Div | 2025 | 39825314 | PubTator, text mining | PubMed |
| Predictive markers of rapid disease progression and chemotherapy resistance in triple-negative breast cancer patients following postoperative adjuvant therapy. | Sci Rep | 2025 | 39748017 | PubTator, text mining | PubMed |
| Regulatory factor X-5/SCL/TAL1 interruption site axis promotes aerobic glycolysis and hepatocellular carcinoma cell stemness. | Kaohsiung J Med Sci | 2025 | 39718123 | PubTator, text mining | PubMed |
| Evaluating the Accuracy of the SIL Score for Predicting the Sepsis Mortality in Emergency Department Triages: A Comparative Analysis with NEWS and SOFA. | J Clin Med | 2024 | 39768710 | PubTator, text mining | PubMed |
| STIL Overexpression Is Associated with Chromosomal Numerical Abnormalities in Non-Small-Cell Lung Carcinoma Through Centrosome Amplification. | Curr Oncol | 2024 | 39727708 | PubTator, text mining | PubMed |
| [Clinical characteristics and prognosis of children with T-lineage acute lymphoblastic leukemia: a single-center study]. | Zhongguo Dang Dai Er Ke Za Zhi | 2024 | 39725394 | PubTator, text mining | PubMed |
| Changes in the tumor microenvironment in recurrent head and neck squamous cell carcinoma and its implication on efficacy of immune checkpoint inhibitors. | Discov Oncol | 2024 | 39567471 | PubTator, text mining | PubMed |
| Prognostic value of tumor-infiltrating lymphocytes in distal extrahepatic bile duct carcinoma. | ESMO Open | 2024 | 39510021 | PubTator, text mining | PubMed |
| Role of Ultrasonographic and Clinicopathological Characteristics in Assessing Stromal Tumor-Infiltrating Lymphocyte Density in Triple-Negative Breast Cancer | Balkan Med J | 2024 | 39324418 | PubTator, text mining | PubMed |
| Development and validation of a nomogram for predicting rapid relapse in triple-negative breast cancer patients treated with neoadjuvant chemotherapy. | Front Cell Dev Biol | 2024 | 39286481 | PubTator, text mining | PubMed |
| The Impact of Neoadjuvant Chemotherapy on Ovarian Cancer Tumor Microenvironment: A Systematic Review of the Literature. | Int J Mol Sci | 2024 | 39000178 | PubTator, text mining | PubMed |
| Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy. | JAMA Oncol | 2024 | 38935352 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6491/papers?page=3